Caeli Vascular, Inc.

medical devices

About

Caeli Vascular has developed a proprietary catheter-based modular multi-modal technology platform for treating venous obstructive disease along the entire disease continuum from early acute through chronic stages. Chronic disease, in particular, remains a significant unmet need afflicting over 250,000 patients in the U.S. annually and is a significant financial burden on the healthcare system. Caeli's system provides infusion, clot fragmentation, and aspiration all within a confined treatment zone that minimizes embolization, bleeding, and blood loss during aspiration. With its multimodal closed system design, the Caeli Vascular SPECTRUM system improves outcomes, enhances safety margins, and reduces costs.

Technologies

Outlook Google Cloud Hosting Mobile Friendly Wix Varnish Remote AI

Keywords

vascular endovascular medical devices dvt medical equipment manufacturing venous disease innovation medical equipment and supplies manufacturing thrombotic disease paradigm thrombectomy venous clot therapy thrombotic disease treatment endovascular care minimally invasive treatment medical device innovation vascular treatment venous therapy device large volume dvt treatment venous thrombus treatment thrombotic disease venous disease treatment transformative venous treatment surgical innovation b2b venous intervention deep vein thrombosis clot removal device risk management pulmonary embolism risk reduction clot removal technology clot removal

Location

4340 Duncan Ave, St. Louis, Missouri, United States, 63110-1110

Related Companies

Companies in the same industry